SEATTLE, Wash. — So far so good for a joint venture partnership that acquired a biotech facility next to Swedish Medical Center-First Hill hospital in the heart of Seattle.
In 2013, the partnership of Dallas-based Trammell Crow Co. and Seattle-based Washington Capital Management (WCM) purchased a facility at 1124 Columbia St., for $42.6 million from Pasadena, Calif.-based Alexandria Real Estate Equities (NYSE: ARE), a real estate investment trust in the life sciences sector.
The full content of this article is only available to paid subscribers. If you are an active subscriber, please log in. To subscribe, please click here: SUBSCRIBE
